Portola Pharmaceuticals Inc Company News
Old Arcived News About Portola Pharmaceuticals Inc
- 3 Stocks Pushing The Drugs Industry Lower.
- Best Stocks for High-Risk Investors.
- Edited Transcript of PTLA earnings conference call or presentation 9-Nov-15 9:30pm GMT.
- Is Portola Pharmaceuticals Inc.
- New Lifetime High For Portola Pharmaceuticals (PTLA).
- Portola Announces Pricing of Public Offering of Common Stock. [at noodls] - Portola Announces Pricing of Public Offering of Common Stock
- Portola Pharmaceuticals (PTLA) Hits New Lifetime High Today.
- Portola Pharmaceuticals (PTLA) In A Perilous Reversal.
- Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematology Annual Meeting and Exposition. [at noodls] - Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematology Annual Meeting and Exposition
- Portola Pharmaceuticals Announces Proposed Offering of Common Stock. [at noodls] - Portola Pharmaceuticals Announces Proposed Offering of Common Stock
- PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits.
- PORTOLA PHARMACEUTICALS INC Financials.
- Portola Pharmaceuticals posts 3Q loss.
- Portola Pharmaceuticals to Host Analyst and Investor Day on November 19. [at noodls] - Portola Pharmaceuticals to Host Analyst and Investor Day on November 19
- Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 14, 2015.
- Portola Pharmaceuticals, Inc. Earnings Q3, 2015.
- Portola reversal agent for Xarelto succeeds in late stage trial.
- The New England Journal of Medicine Publishes Results of Portola Pharmaceuticals’ Phase 3 ANNEXA Studies of Andexanet Alfa. [GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Nov. 11, 2015-- Portola Pharmaceuticals announced that the results of its Phase 3 ANNEXA™ studies were published online today by The New England Journal of Medicine. ANNEXA-R ...
Portola Pharmaceuticals Inc Short Company Overview:
Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.